Predictive models assess orexin-A deficiency and its impact on oxidative stress and brain-derived neurotrophic factor (BDNF) expression, offering potential therapeutic targets [17,18,19,20]. This evidence concerns the gene BDNF and hyperinsulinemic hypoglycemia, familial, 4.